- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00840060
Efficacy of AMALS in Treating Language Impairment in Children (AMALS)
AMALS: Addressing Multiple Aspects of Language Simultaneously: A Randomized Clinical Trial
The goal of this proposal is to examine the efficacy of a manualized treatment intervention, AMALS: Addressing Multiple Aspects of Language Simultaneously, which is designed to remediate semantic, morphological, and syntactic aspects of language in preschool children with language impairment. This study will target preschool children with language impairment living in a region characterized by nonmainstream dialects.
Questions driving this work are:
- Will children participating in the AMALS treatment exhibit greater semantic, morphological, and syntactic complexity on multiple outcome measures at the completion of the intervention compared to a Discrete Trial Approach (DTA) group?
- Will these gains be maintained at one-month follow up?
- What is the impact of dialect on dependent variables, specifically morphosyntactic abilities?
To answer these questions a randomized clinical trial will be conducted comparing AMALS, an integrated approach to treatment, with DTA, an additive approach to therapy. In this study rather than restrict the ethnic and cultural backgrounds of this population, children's use of dialect will be uniquely identified and examined.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
Texas
-
Orange, Texas, United States, 77631
- West Orange Cove Consolidated Independent School District
-
Orange, Texas, United States, 77632
- Little-Cypress Mauriceville Consolidated School District
-
Port Arthur, Texas, United States, 77640
- Port Arthur Independent School District
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Demonstrate sufficient intelligibility as determined by a score of 85% on percent consonant correct (PCC) measures;
- Demonstrate sufficient phonological ability to use grammatical morphemes as determined by use of word-final /s, z, t, d/ on sound- in-word subtest from the Goldman-Fristoe Test of Articulation-2 (GFTA; Goldman & Fristoe, 2000)
- Nonverbal IQ above 70 as scored on the Columbia Mental Maturity Scale (CMMS; Burgemeister, Blum, & Lorge, 1972);
- Below 1SD on the Diagnostic Evaluation of Language Variation: Norm-referenced Test (DELV; Seymour, Roeper & de Villiers, 2005);
- Below 1.39SD on the Structured Photographic Expressive Language Test-Preschool (SPELT-P; Werner & Kresheck, 1983);
- Documentation from teachers and/or parents of impressions of language status in comparison with peers;
- More than one standard deviation below the mean on both levels 3 and 4 of the Preschool Language Assessment Instrument (PLAI; Blank, Rose, & Berlin, 1978).
Exclusion Criteria:
- English as the primary language
- No oral-motor impairment
- No hearing impairment
- No co-morbid psychiatric or neurological impairments
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: AMALS
Addressing multiple aspects of language simultaneously
|
Addressing multiple aspects of language simultaneously
|
|
EXPERIMENTAL: DTA
Discrete Trial Approach
|
Discrete Trial Approach
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Language Sample Analysis
Time Frame: Language samples were obtained pre-treatment, post-treatment, and at one-month follow-up.
|
Samples were transcribed and segmented by utterance.
Each was coded categorically.
Reported measures include percentage of utterances at the interpretive/inferential label, percentage of utterances with one or more t-unit (i.e., noun phrase + verb phrase), percentage of utterances that required copula (is/are) or auxiliary (is/are) that were produced.
|
Language samples were obtained pre-treatment, post-treatment, and at one-month follow-up.
|
|
Number of Verb Structures Per Utterance
Time Frame: Pre-treatment, post-treatment, 1-month follow-up
|
Samples were transcribed and segmented by utterance.
Utterances were analyzed for novel verb structures.
Structures were included if they were produced more than one time.
|
Pre-treatment, post-treatment, 1-month follow-up
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Monica L Bellon-Harn, Ph.D., Lamar University
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RDC009027A-01A2
- 1R15DC009027-01A2 (NIH)
- NIDCD RDC009027A-01A2
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.